Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 06, 2018 11:24 ET | Source: Amarantus Bioscience Holdings, Inc.

Amarantus Re-acquires Rights to Alzheimer's Blood Diagnostic LymPro Test

NEW YORK, April 06, 2018 (GLOBE NEWSWIRE) -- Via OTC PR Wire -- Amarantus Bioscience Holdings, Inc. (OTC Pink:AMBS) (the "Company" or AMBS), a US-based JLABS-alumnus biotechnology holding company...
April 05, 2018 08:00 ET | Source: Amarantus Bioscience Holdings, Inc.

Amarantus Appoints Barney Monte as Interim COO/CFO and Promotes Brian Harvey to Chief Regulatory Advisor

NEW YORK, April 05, 2018 (GLOBE NEWSWIRE) -- Via OTC PR Wire – Amarantus Bioscience Holdings, Inc. (OTC Pink:AMBS) (the "Company" or AMBS), a US-based JLABS-alumnus biotechnology holding company,...
April 02, 2018 09:49 ET | Source: Amarantus Bioscience Holdings, Inc.

Amarantus Relocates Headquarters to WeWork at 110 Wall St. in New York City

SAN FRANCISCO, April 02, 2018 (GLOBE NEWSWIRE) -- Via OTC PR Wire -- Amarantus Bioscience Holdings, Inc. (OTCPink:AMBS) (the "Company" or AMBS), a US-based JLABS-alumnus biotechnology holding...
March 28, 2018 13:41 ET | Source: Amarantus Bioscience Holdings, Inc.

Amarantus Completes Tender Exchange of Convertible Securities; CEO attending CNBC's Healthy Returns conference in New York City

SAN FRANCISCO, March 28, 2018 (GLOBE NEWSWIRE) -- Via OTC PR Wire -- Amarantus Bioscience Holdings, Inc. (OTC Pink:AMBS) (the "Company" or AMBS), a US-based biotechnology holding company with...
March 08, 2018 08:00 ET | Source: Amarantus Bioscience Holdings, Inc.

Elto Pharma Receives Notice of Allowance in Australia for Patent Covering Eltoprazine in the Treatment of Parkinson's Levodopa-induced Dyskinesia

SAN FRANCISCO, March 08, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE--Elto Pharma, Inc., a specialty pharmaceutical, clinical-stage wholly-owned subsidiary of Amarantus Bioscience Holdings, Inc....
March 05, 2018 08:00 ET | Source: Amarantus Bioscience Holdings, Inc.

Elto Pharma to Present and Participate in Neuroscience Panel at Sachs BioCapital USA Forum

SAN FRANCISCO, March 05, 2018 (GLOBE NEWSWIRE) -- Via OTC PR Wire -- Elto Pharma, Inc., an orphan specialty pharmaceutical, clinical-stage wholly-owned subsidiary of Amarantus Bioscience Holdings,...
March 01, 2018 06:00 ET | Source: Amarantus Bioscience Holdings, Inc.

MANF Therapeutics Announces the Issuance of U.S. Patent #9,891,231

Allowed claims include the treatment of Type 1 and Type 2 DiabetesPatent protects exclusivity for MANF in diabetes inthe US into 2032 SAN FRANCISCO, March 01, 2018 (GLOBE NEWSWIRE) -- via OTC PR...
February 26, 2018 17:56 ET | Source: Amarantus Bioscience Holdings, Inc.

Amarantus Enters into Definitive Agreements for up to $1.5 Million in Funding

At least 96% of eligible securities participating in Tender ExchangeCEO to present at BIOCOM Global Life Science Partnering Conference in San Diego SAN FRANCISCO, Feb. 26, 2018 (GLOBE NEWSWIRE) --...
January 29, 2018 09:00 ET | Source: Amarantus Bioscience Holdings, Inc.

Amarantus Subsidiary MANF Therapeutics Announces Positive Independent Peer-Reviewed Pre-Clinical Data for MANF in Parkinson’s Disease

SAN FRANCISCO, Jan. 29, 2018 (GLOBE NEWSWIRE) -- Via OTC PR Wire -- Amarantus Bioscience Holdings, Inc. (OTCPK:AMBS), a US-based biotechnology holding company with wholly-owned subsidiaries...
January 23, 2018 09:59 ET | Source: Amarantus Bioscience Holdings, Inc.

Amarantus Subsidiary Cutanogen Corporation Announces Issuance of US Patent 14/299,480 Covering ESS, Pigmented ESS and Gene Therapy-Modified ESS

Patent Issuance Opens Potential to genetically modify cells used to produce ESS Peer-Reviewed publication demonstrates improved donor cosmetic skin color matching of melanocytes-implanted ESS vs....